Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.
Viazis N, Katopodi K, Karamanolis G, Denaxas K, Varytimiadis L, Galanopoulos M, Tsoukali E, Kamberoglou D, Christidou A, Karamanolis DG, Papatheodoridis G, Mantzaris GJ. Viazis N, et al. Among authors: tsoukali e. Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1054-1058. doi: 10.1097/MEG.0000000000000925. Eur J Gastroenterol Hepatol. 2017. PMID: 28628496
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.
Kopylov U, Verstockt B, Biedermann L, Sebastian S, Pugliese D, Sonnenberg E, Steinhagen P, Arebi N, Ron Y, Kucharzik T, Roblin X, Ungar B, Shitrit AB, Ardizzone S, Molander P, Coletta M, Peyrin-Biroulet L, Bossuyt P, Avni-Biron I, Tsoukali E, Allocca M, Katsanos K, Raine T, Sipponen T, Fiorino G, Ben-Horin S, Eliakim R, Armuzzi A, Siegmund B, Baumgart DC, Kamperidis N, Maharshak N, Maaser C, Mantzaris G, Yanai H, Christodoulou DK, Dotan I, Ferrante M. Kopylov U, et al. Among authors: tsoukali e. Inflamm Bowel Dis. 2018 Oct 12;24(11):2442-2451. doi: 10.1093/ibd/izy155. Inflamm Bowel Dis. 2018. PMID: 29788318
Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.
Bamias G, Kokkotis G, Gizis M, Kapizioni C, Karmiris K, Koureta E, Kyriakos N, Leonidakis G, Makris K, Markopoulos P, Michalopoulos G, Michopoulos S, Papaconstantinou I, Polymeros D, Siakavellas SI, Triantafyllou K, Tsironi E, Tsoukali E, Tzouvala M, Viazis N, Xourafas V, Zacharopoulou E, Zampeli E, Zografos K, Papatheodoridis G, Mantzaris G. Bamias G, et al. Among authors: tsoukali e. Dig Dis Sci. 2022 Mar;67(3):1007-1017. doi: 10.1007/s10620-021-06907-5. Epub 2021 Mar 9. Dig Dis Sci. 2022. PMID: 33751325 Free PMC article.
Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease.
Ellul P, Schembri J, Vella Baldacchino A, Molnár T, Resal T, Allocca M, Furfaro F, Dal Buono A, Theodoropoulou A, Fragaki M, Tsoukali E, Mantzaris GJ, Phillips FM, Radford S, Moran G, Gonzalez H, Sebastian S, Fousekis F, Christodoulou D, Snir I, Lerner Z, Yanai H, Michalopoulos G, Tua J, Camilleri L, Papamichael K, Karmiris K, Katsanos K. Ellul P, et al. Among authors: tsoukali e. J Crohns Colitis. 2023 Apr 19;17(4):489-496. doi: 10.1093/ecco-jcc/jjac169. J Crohns Colitis. 2023. PMID: 36322687
16 results